One Stop Shop for All Your Market Research Reports

Global Small Molecule API market Estimation & Forecast, 2013-2027

Introduction The global small molecule API market was valued at $ 132,877.3 million in 2016 and expected to reach $ 279,687.1 million by 2027 at a CAGR of 7 % during the forecast period. The major factors responsible for the growth of global Small molecule API market are growing demand for newly developed small molecules drugs, growing trend of outsourcing and growing pharmaceutical industry in developing nations. The growth barriers are and austerity measures in Europe among others. The market is majorly categorized on the basis of types which is further segmented into synthetic/chemical API and biological API. On the basis of application the market is segmented into cardiovascular, oncology, diabetes and immunological disorders. On the basis of manufacturing methods the market is segmented into in-house manufacturing and contract manufacturing and geographic regions. Globally, North America holds the largest market share of global small molecule API market, registering 38.84 % in 2016. The scope of global small molecule API market study includes the market value, market size and a detailed analysis of vendor products and strategies. Key Players The leading players of the global small molecule API market are Albemarle Corporation, Allergan Plc, Aurobindo Pharma, Cambrex Corporation, Dr. Reddy*s laboratories ltd., Glaxosmithkline Plc, Lonza , Merck Sharp & Dohme Corp., Mylan N.V., Pfizer Inc., Novartis AG, Siegfried AG , Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd. and others. Study Objectives of Small molecule API Market Development and Demand Forecast to 2027 Market * To provide insights about factors, influencing and affecting the market growth * To provide historically and forecast revenue of the market segments and sub-segments with respect to regional markets and their countries * To provide historically and forecast revenue of the market segments based on type, and sub-segment for global Small molecule API market * To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market * To provide economic factors that influence the global Small molecule API market Target Audience * Small molecule API companies * Raw Material Suppliers * Key executive (CEO and COO) and strategy growth manager Key Findings * On the basis of types, synthetic/chemical API accounted for the largest market share of 81.31 % in 2016. * US accounted for the largest market share of 59.75 % in 2016, with a market value of USD 30,848.3 million and is projected to grow at a CAGR of 6.6 % during the forecast period. The reports also cover country level analysis: * North America * US * Canada * Europe * Western Europe * Germany * France * U.K. * Italy * Spain * Rest of Western Europe * Eastern Europe * Asia-Pacific * China * Japan * India * Republic of Korea * Rest of Asia-Pacific * Middle East & Africa
TABLE OF CONTENTS 1 INTRODUCTION 12 1.1 DEFINITION 12 1.2 SCOPE OF STUDY 12 1.2.1 RESEARCH OBJECTIVE 12 1.2.2 ASSUMPTIONS & LIMITATIONS 13 1.2.2.1 ASSUMPTIONS 13 1.2.2.2 LIMITATIONS 13 1.3 MARKET STRUCTURE: 13 2 RESEARCH METHODOLOGY 14 2.1 RESEARCH PROCESS: 14 2.2 PRIMARY RESEARCH 15 2.3 SECONDARY RESEARCH: 15 3 MARKET DYNAMICS 16 3.1 DRIVERS 16 3.1.1 GROWING DEMAND FOR NEWLY DEVELOPED SMALL MOLEC
Inquiry Before Buying

Request Sample

Share This Report

Our Clients

Payment Mode
Single User US $ 4450
Corporate User US $6250
About this Report
Report ID 102079
Category
  • Healthcare
Published on 17-May
Number of Pages 110
Publisher Name Market Research Future
Editor Rating
★★★★★
★★★★★
(33)